Literature DB >> 16005098

Interleukin-12p40 gene (IL-12B) polymorphism and Type 1 diabetes mellitus in Japanese: possible role in subjects without having high-risk HLA haplotypes.

Jian Mei Yang1, Shoichiro Nagasaka, Toshimitsu Yatagai, Tomoatsu Nakamura, Ikuyo Kusaka, San-e Ishikawa, Toshikazu Saito, Shun Ishibashi.   

Abstract

The present study was undertaken to clarify a role of interleukin-12p40 gene (IL-12B) polymorphism, located on chromosome 5q33-34 (IDDM 18), in Japanese subjects with Type 1 diabetes mellitus (T1DM) and autoimmune thyroid diseases (AITD). In 179 subjects with T1DM, 166 with AITD (128 with Graves' disease and 38 with Hashimoto's thyroiditis) and 115 healthy control subjects, the IL-12B 3'UTR A-C polymorphism was determined by PCR-RFLP method. In T1DM subjects, the genotype was also analyzed in relation to human leukocyte antigen (HLA)-DRB1-DQB1 haplotype status. There was a weak difference in the distribution of the genotype frequency between T1DM and control subjects, and the C allele frequency was higher in T1DM subjects (P<0.05). In 68 T1DM subjects without having high-risk HLA haplotypes to T1DM in this population, the genotype distribution and C allele frequency was significantly different from control subjects without high-risk HLA haplotypes (P<0.01), and from T1DM subjects with high-risk HLA haplotypes (n=111) (P<0.05). There was no difference in the genotype and allele frequencies between AITD and control subjects. In conclusion, the IL-12B 3'UTR A-C polymorphism did not seem to play a major role on genetic susceptibility to T1DM and AITD in Japanese, although the polymorphism conferred susceptibility in T1DM subjects without having high-risk HLA haplotypes. The IL-12B 3'UTR A-C polymorphism would be considered as a supplementary risk factor to T1DM in conjunction with HLA haplotypes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16005098     DOI: 10.1016/j.diabres.2005.05.005

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  5 in total

1.  Haplotypes of IL12B promoter polymorphisms condition susceptibility to severe malaria and functional changes in cytokine levels in Thai adults.

Authors:  Chintana Phawong; Collins Ouma; Piyatida Tangteerawatana; Jarinee Thongshoob; Tom Were; Yuvadee Mahakunkijcharoen; Duangrurdee Wattanasirichaigoon; Douglas Jay Perkins; Srisin Khusmith
Journal:  Immunogenetics       Date:  2010-04-13       Impact factor: 2.846

2.  Evaluation of IL12B as a candidate type I diabetes susceptibility gene using data from the Type I Diabetes Genetics Consortium.

Authors:  G Morahan; E McKinnon; J Berry; B Browning; C Julier; F Pociot; I James
Journal:  Genes Immun       Date:  2009-12       Impact factor: 2.676

3.  Association of polymorphisms in the IL-18 and IL-12 genes with susceptibility to Type 1 diabetes in Turkish patients.

Authors:  A E Altinova; D Engin; E Akbay; M Akturk; F Toruner; R Ersoy; I Yetkin; M Arslan
Journal:  J Endocrinol Invest       Date:  2009-12-22       Impact factor: 4.256

4.  Association of IL12B polymorphisms with susceptibility to Graves ophthalmopathy in a Taiwan Chinese population.

Authors:  Yu-Huei Liu; Ching-Chu Chen; Li-Ling Liao; Lei Wan; Chang-Hai Tsai; Fuu-Jen Tsai
Journal:  J Biomed Sci       Date:  2012-11-19       Impact factor: 8.410

5.  The Association of IL-12b Polymorphisms with Systemic Lupus Erythematosus in Chinese Han Population.

Authors:  Yong Shao; Jie Zhang; Yuewen Chen; Qi Wu; Ming Guan; Bo Yu; Jun Wan; Wei Zhang
Journal:  Int J Rheumatol       Date:  2012-05-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.